Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest antibodies Stories

2012-08-08 02:27:17

ROCKVILLE, Md. and SAN FRANCISCO, Aug. 8, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE Amex: SYN), a developer of synthetic biologics and innovative medicines for unmet medical needs, and Intrexon Corporation (Intrexon), a synthetic biology company that utilizes its proprietary technologies to provide control over cellular function, today entered into a second worldwide exclusive channel collaboration through which Synthetic Biologics intends to develop and commercialize a series of...

Allergies Could Reduce Risk Of Brain Tumors
2012-08-05 06:04:08

redOrbit Staff & Wire Reports - Your Universe Online An international team of scientists has discovered evidence supporting the theory that people with allergies could have a reduced risk of contracting a serious form of cancer that starts in the brain. In the study, which has been published online in the Journal of the National Cancer Institute, the researchers analyzed stored blood samples from both male and female patients who later went on to develop glioma, which form from...

2012-08-01 23:07:09

The deadliest form of malaria is caused the protozoan Plasmodium falciparum. During its life-cycle in human blood, the parasite P. falciparum expresses unique proteins on the surface on infected blood cells. Antibodies to these proteins are associated with protection from malaria, however, the identity of surface protein(s) that elicit the strongest immune response is unknown. Dr. James Beeson and colleagues at the Walter and Eliza Hall Institute of Medical Research in Victoria, Australia...

2012-08-01 02:28:53

LEBANON, N.H. and CAMBRIDGE, Mass., Aug. 1, 2012 /PRNewswire/ -- Adimab, LLC, the technology leader in the discovery and optimization of fully human therapeutic antibodies, and Mersana Therapeutics, Inc., a next-generation antibody-drug conjugate (ADC) company, today announced the initiation of a joint effort to offer integrated antibody discovery and ADC technologies. The alliance is built to offer pharmaceutical companies seamless access to Adimab's world-class antibodies that have been...

2012-07-31 02:27:15

SEATTLE, July 31, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today reported that it believes it has identified the proteins that activate the alternative pathway of the complement system, an important part of the immune system. The work was led by the Company's collaborator, Professor Wilhelm Schwaeble of the University of Leicester, and Omeros controls the worldwide exclusive rights to this discovery. The complement system plays an important role in the inflammatory response and...

2012-07-24 23:00:20

A new study presented on July 17th, 2012, at the Alzheimer's Association International Conference 2012 in Vancouver revealed Alzheimer's disease symptoms long-term (three-year) stabilization with Gammagard. Gammagard, manufactured by Baxter, is an intravenous solution that is made from human plasma (intravenous immunoglobulin, or IVIG). It is a sterile solution, which helps the body maintain immunity and fight disease. In February 1994, Gammagard was pulled off from the global market because...

2012-07-19 23:01:27

Specialty biotech distributor BDI Pharma announced that Sales Revenues through the first two fiscal quarters of 2012 represented an increase of more than thirty-five percent (35%) compared with the same time period in 2011, with both Hemophilia and IVIG sales continuing to track ahead of 2011 in both revenue and units of distribution. Columbia, SC (PRWEB) July 19, 2012 BDI Pharma, Inc. (BDI), the nation's fastest growing national distributor of specialty biotherapeutics, announced that...

2012-07-19 14:21:27

ROCKVILLE, Md., July 19, 2012 /PRNewswire/ -- OriGene Technologies, Inc. and Canada's Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) today announced the selection of OriGene Technologies as a major collaboration and development partner to implement blood-based protein assays in heart and kidney transplantation. This multi-year, collaborative project funded by multiple partners will provide monitoring and predictive blood tests, based upon OriGene's extensive expertise...

2012-07-19 02:25:49

CARLSBAD, Calif., July 19, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it has signed a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research. The first 58 of 200 highly-specific antibodies to be...

2012-07-19 00:14:16

In a long-term study of people infected with the hepatitis C virus (HCV), researchers found increased deaths from both liver-related and non-liver related diseases in patients with active infections who had not cleared their infection. The study, published in the Journal of Infectious Diseases and available online, found increased mortality in patients with chronic HCV infection–that is, with detectable levels of HCV genetic material, or RNA, in their blood–suggesting that...